Astedt B

No ORCID on file · 5 papers in corpus · active 1971-1998

Study types

  • article 3
  • other 1

Condition tags

  • endometriosis 4
article 1998
Fibrinolysis in the Peritoneal Fluid During Adhesions, Endometriosis and Ongoing Pelvic Inflammatory Disease
Inflammation ·doi:10.1023/a:1022322814288

The concentrations of the specific activators (u-PA and t-PA) and the specific inhibitors (PAI-1 and PAI-2) of the fibrinolytic system were analyzed in the peritoneal fluid in women suffering from intra-abdominal adhesions, endometriosis or…

article 1998
Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00285-4

ObjectiveTo determine whether there is a difference in fibrinolytic compounds in endometriotic tissue, endometrium, peritoneal fluid (PF), and plasma from women with endometriosis and in endometrium and PF from healthy women.DesignProspecti…

other 1994
Treatment with a GnRH analogue: effects on hemostatic risk factors for thrombo-embolic disease
International journal of fertility and menopausal studies

OBJECTIVE: Steroid hormones, especially estrogens, are known to affect hemostatic risk factors for thromboembolism, cardiovascular disease, and stroke. We examined these risk factors during depression of the serum estradiol concentration by…

article 1984
Plasminogen activators in endometriosis
Acta obstetricia et gynecologica Scandinavica. Supplement ·doi:10.3109/00016348409156976
1971
Fibrin degradation products and ovarian tumours.
British medical journal ·doi:10.1136/bmj.4.5785.458

Fibrin degradation products (F.D.P.) were determined in the serum of 163 women in whom ovarian tumours had been suspected on palpation at gynaecological examination and who were afterwards examined by laparoscopy or subjected to laparotomy.…